NEWSROOM

Newsroom

By InventVacc January 30, 2022
NRC recently gave the licence to manufacture the Type A vaccine to Vancouver-based InventVacc Biologicals Inc.
By InventVacc January 29, 2022
Licensed to InventVacc Biologicals Inc. for manufacturing in preparation for clinical trials
By InventVacc January 29, 2022
InventVacc is pleased to contribute over four decades of vaccine manufacturing expertise to the manufacturing of the Hia vaccine.
Share by: